Dr Reddy's Laboratories share price logo

Dr Reddy's Laboratories

NYSE: RDY

$12.20

+0.52

(+4.45%)

Live

as on

Dr Reddy's Laboratories Stock Performance

as on September 18, 2026 at 6:14 am IST

  • Day's Low

    Day's High

    $12.05
    $12.36
    downward going graph

    1.23%

    Downside

    1.31%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.36
    $15.67
    downward going graph

    6.89%

    Downside

    28.44%

    Upside

    downward going graph

Dr Reddy's Laboratories share price movements today

Previous Close
$11.68
Open
$12.06
Volume
2.7M
Market Cap
$10.1B
Dividend Yield
0.72%
Day's Low - High
$12.05 - $12.36
52 Week Low - High
$11.36 - $15.67

Dr Reddy's Laboratories Historical Returns

1 Month Return
-3.55 %
3 Month Return
-11.18 %
1 Year Return
-21.4 %
3 Year Return
-16.39 %
5 Year Return
-11.98 %

Dr Reddy's Laboratories Stock Fundamentals & Key Indicators

Check Dr Reddy's Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.1B

EPS (TTM)

56.33

Dividend Yield

0.72%

Quarterly Earnings Growth YOY

-0.69%

PE Ratio (TTM)

28.88

Industry PE ratio

29.81

PEG Ratio

1.5827

EBITDA

54.7B

Revenue (TTM)

331.2B

Profit Margin

10.00%

Return On Equity TTM

8.84%

Dr Reddy's Laboratories Stock Valuation

Track how Dr Reddy's Laboratories P/E has moved over time to understand its valuation trends.

Dr Reddy's Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (0.20x)

March 31, 2025

Today (28.88x)

September 17, 2026

Industry (29.81x)

September 17, 2026

Highest (32.13x)

June 30, 2026

LowHigh

Today’s Price to Earnings Ratio: 28.88x

Dr Reddy's Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr Reddy's Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Dr Reddy's Laboratories image
Dr Reddy's Laboratories
BUY$10.1B-11.98%28.8810.00%0.72%
United Therapeutics image
United Therapeutics
BUY$21.5B149.14%16.5586.14%0.00%
Viatris image
Viatris
HOLD$19.1B25.42%-46.2534.83%2.88%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$40.5BNA18.7765.57%1.34%
Zoetis image
Zoetis
BUY$30.4B-63.22%12.0770.87%2.85%
See all

Stock Returns calculator for Dr Reddy's Laboratories Stock including INR - Dollar returns

The Dr Reddy's Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dr Reddy's Laboratories investment value today

Current value as on today

₹89,617

Returns

-₹10,383

(-10.38%)

Returns from Dr Reddy's Laboratories Stock

-₹17,900 (-17.9%)

Dollar Impact

₹7,517 (+7.52%)

Analyst Recommendation on Dr Reddy's Laboratories Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Dr Reddy's Laboratories. Average target price of $13.34

Dr Reddy's Laboratories Share Price Target

Get share price movements and forecasts by analysts on Dr Reddy's Laboratories.

What analysts predicted

8.55%UPSIDE

Target Price

$13.34

Current Price

$12.2

Analyzed by

1 Analysts

Target

$13.34

Dr Reddy's Laboratories target price $13.34, a slight upside of 8.55% compared to current price of $12.2. According to 1 analysts rating.

Indian Investors' Interest in Dr Reddy's Laboratories Stock

Investment in Dr Reddy's Laboratories Shares on INDmoney has dropped by -39.66% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-39.66% versus previous 30 day period

Search interest for Dr Reddy's Laboratories Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Dr Reddy's Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
852
919
956
983
983
85,452
88,051
87,268
76,331
81,183
Gross Profit
499
555
570
577
546
48,627
48,140
46,806
34,215
37,762
Operating Income
14,959
17,925
17,551
18,720
17,647
17,475
17,513
14,238
473
2,971
EBITDA
20,322
21,757
23,899
24,279
25,264
24,642
24,308
19,560
8,758
2,971
Interest Expense
593
598
757
818
656
830
907
951
1,073
1,262
Depreciation
3,713
3,810
3,975
4,719
4,554
4,765
5,051
5,213
5,559
5,372
Income Before Tax
16,016
18,821
19,167
18,742
20,054
19,047
18,350
15,429
2,021
5,558
Income Tax Expense
2,946
4,901
5,752
4,704
4,182
4,951
4,082
3,533
-217
1,184
Net Income
157
166
149
166
184
14,178
14,372
12,098
2,235
4,461
Net Profit Margin
18.45%
18.14%
15.66%
16.91%
18.74%
16.59%
16.32%
13.86%
2.93%
5.50%

Dr Reddy's Laboratories Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
2,138
2,184
2,207
2,340
35
2,813
2,989
3,361
3,763
353,471
Gross Profit
1,189
1,173
1,196
1,260
17
1,493
1,694
1,970
2,201
186,518
Operating Income
13,498
11,917
20,888
15,993
431
29,476
57,144
67,729
71,843
48,867
EBITDA
24,775
23,627
35,522
41,785
534
45,080
74,431
88,422
96,671
83,293
Interest Expense
634
788
889
13
970
958
1,428
1,711
2,829
3,933
Depreciation
-
11,710
12,190
12,472
12,796
11,824
12,502
14,841
17,058
20,588
Income Before Tax
14,653
14,341
22,443
18,032
355
32,298
60,367
71,870
76,784
57,678
Income Tax Expense
2,614
4,535
3,648
-1,466
123
8,730
15,300
16,186
19,539
12,995
Net Income
182
150
269
261
3
309
548
670
653
45,087
Net Profit Margin
8.55%
6.90%
12.22%
11.17%
9.09%
10.99%
18.33%
19.95%
17.37%
12.76%

Dr Reddy's Laboratories Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
13,920
13,415
14,038
15,872
14,096
14,268
11,897
2,235
4,348
Operating Cash Flow
8,496
9,316
6,620
21,996
14,629
15,573
10,908
15,437
-927
Investing Cash Flow
-20,248
-19,071
-5,458
-13,300
-19,192
-9,543
-10,292
-28,222
3,836
Financing Cash Flow
9,541
16,150
590
-7,370
-1,203
-5,323
7,777
8,738
-7,117
Change in Cash
-2,194
6,372
1,747
1,561
-5,589
902
8,751
-4,234
-4,169

Dr Reddy's Laboratories Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
9,806
18,795
19,498
19,149
23,568
60,485
55,684
57,245
45,087
Operating Cash Flow
18,029
28,704
29,841
35,703
28,108
58,873
45,433
46,428
56,645
Investing Cash Flow
-14,883
-7,727
-4,923
-22,660
-26,387
-41,373
-40,283
-58,077
-70,533
Financing Cash Flow
-4,440
-21,326
-25,159
-298
-2,422
-26,861
-3,763
18,911
13,395
Change in Cash
-1,237
-314
-266
12,858
32
-9,073
1,328
7,486
-875

Mutual Funds that own Dr Reddy's Laboratories Stock

Check out the Mutual Funds with significant holdings in Dr Reddy's Laboratories.

Funds
Holdings
Shares Held
DFA INVESTMENT DIMENSIONS GROUP INC
0.330047%
2754709
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
0.266802%
2226840
VANGUARD WHITEHALL FUNDS
0.215034%
1794763
VANGUARD STAR FUNDS
0.104724%
874071
SEI INSTITUTIONAL INTERNATIONAL TRUST
0.062983%
525686
See all

Global Institutional Holdings in Dr Reddy's Laboratories

Funds
Holdings
AB Funds
0.45%
Vanguard
0.27%
Invesco
0.24%
Avantis
0.22%
State Street
0.2%
See all

Dr Reddy's Laboratories News & Key Events

  • img

    Today's Timeline - 10 September

    Thu, 09:26 PM

    -

    Dr. Reddy's issues 375 new shares under ESOP, increasing share capital to Rs. 83.46 crore, aligning employee interests with shareholder value.

Insights on Dr Reddy's Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 76.33B → 81.18B (in $), with an average increase of 6.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 2.23B → 4.46B (in $), with an average increase of 49.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 76.9% return, outperforming this stock by 98.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 74.2% return, outperforming this stock by 90.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, RDY stock has moved down by -17.7%

About Dr Reddy's Laboratories

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
OrganisationDr Reddy's Laboratories
Headquarters8-2-337, Road No. 3, Hyderabad, India, 500034
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Erez Israeli M.B.A.
E-voting on sharesClick here to vote

Key Management of Dr Reddy's Laboratories

Name

Title

Mr. Sanjay Sharma B.Tech.

Executive VP, COO & Member of Management Council

Mr. Patrick Aghanian B.A., M.B.A.

Head of Consumer Health Organization & Member of Management Council

Mr. Bhethanabottla S. Phanimitra

Chief Digital & Information Officer and Member of the Management Council

Mr. Kallam Satish Reddy B.Tech., M.S.

Chairman of the Board & Member of the Management Council

Mr. Erez Israeli M.B.A.

CEO & Member of the Management Council

Mr. Mannam Venkatanarasimham

CFO & Member of the Management Council

Mr. Deepak Sapra M.B.A.

CEO ? API and Services & Member of Management Council

Mr. Gunupati Venkateswara Prasad B.E.

Co-Chairman, MD & Member of Management Council

Mr. Krishna K. Venkatesh B.Pharma M.S.

Global Head of IPDO, Integrated Product Development & Member of the Management Council

Mr. Motupalli Venkata Ramana M.B.A.

CEO of Global Generics & Member of Management Council

FAQs

What is Dr Reddy's Laboratories share price today?

Dr Reddy's Laboratories share price today is $12.20 as on . Dr Reddy's Laboratories share today touched a day high of $12.36 and a low of $12.05.

What is the 52 week high and 52 week low for Dr Reddy's Laboratories share?

Dr Reddy's Laboratories share touched a 52 week high of $15.67 on and a 52 week low of $11.36 on . Dr Reddy's Laboratories stock price today i.e. is trending at $12.20,which is 22.14% down from its 52 week high and 7.39% up from its 52 week low.

What is Dr Reddy's Laboratories's market capitalisation today?

Dr Reddy's Laboratories market capitalisation is $0.01T as on .

How to invest in Dr Reddy's Laboratories Stock (RDY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dr Reddy's Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dr Reddy's Laboratories Shares that will get you 0.1230 shares as per Dr Reddy's Laboratories share price of $12.20 per share as on September 18, 2026 at 12:44 am IST.

What is the minimum amount required to buy Dr Reddy's Laboratories Stock (RDY) from India?

Indian investors can start investing in Dr Reddy's Laboratories (RDY) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Dr Reddy's Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Dr Reddy's Laboratories share’s latest price of $12.20 as on September 18, 2026 at 12:44 am IST, you will get 0.8197 shares of Dr Reddy's Laboratories. Learn more about fractional shares .

What are the returns that Dr Reddy's Laboratories has given to Indian investors in the last 5 years?

Dr Reddy's Laboratories stock has given -11.98% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?